197 related articles for article (PubMed ID: 32761352)
41. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
[TBL] [Abstract][Full Text] [Related]
42. Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat.
Esmaeili MH; Movahedi M; Faraji A; Haghdoost-Yazdi H
Neurotoxicol Teratol; 2012; 34(5):489-94. PubMed ID: 22789434
[TBL] [Abstract][Full Text] [Related]
43. Intracerebroventricularly and systemically delivered inhibitor of brain CYP2B (C8-Xanthate), even following chlorpyrifos exposure, reduces chlorpyrifos activation and toxicity in male rats.
Khokhar JY; Tyndale RF
Toxicol Sci; 2014 Jul; 140(1):49-60. PubMed ID: 24798379
[TBL] [Abstract][Full Text] [Related]
44. Endogenously occurring beta-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease.
Matsubara K; Gonda T; Sawada H; Uezono T; Kobayashi Y; Kawamura T; Ohtaki K; Kimura K; Akaike A
J Neurochem; 1998 Feb; 70(2):727-35. PubMed ID: 9453568
[TBL] [Abstract][Full Text] [Related]
45. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
Mueller M; Maldonado-Adrian C; Yuan J; McCann UD; Ricaurte GA
J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
[TBL] [Abstract][Full Text] [Related]
46. Regio- and stereoselective oxidation of propranolol enantiomers by human CYP2D6, cynomolgus monkey CYP2D17 and marmoset CYP2D19.
Narimatsu S; Nakata T; Shimizudani T; Nagaoka K; Nakura H; Masuda K; Katsu T; Koeda A; Naito S; Yamano S; Miyata A; Hanioka N
Chem Biol Interact; 2011 Feb; 189(3):146-52. PubMed ID: 21184751
[TBL] [Abstract][Full Text] [Related]
47. Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Kent R; Won KJ; Jeong H
Drug Metab Dispos; 2017 Apr; 45(4):346-352. PubMed ID: 28153841
[TBL] [Abstract][Full Text] [Related]
48. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan.
Tyndale RF; Li Y; Li NY; Messina E; Miksys S; Sellers EM
Drug Metab Dispos; 1999 Aug; 27(8):924-30. PubMed ID: 10421620
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of CYP2D6 activity by treatment with propranolol and the role of 4-hydroxy propranolol.
Rowland K; Yeo WW; Ellis SW; Chadwick IG; Haq I; Lennard MS; Jackson PR; Ramsay LE; Tucker GT
Br J Clin Pharmacol; 1994 Jul; 38(1):9-14. PubMed ID: 7946944
[TBL] [Abstract][Full Text] [Related]
50. Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.
Yu AM; Idle JR; Byrd LG; Krausz KW; Küpfer A; Gonzalez FJ
Pharmacogenetics; 2003 Mar; 13(3):173-81. PubMed ID: 12618595
[TBL] [Abstract][Full Text] [Related]
51. Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.
Miller RT; Miksys S; Hoffmann E; Tyndale RF
Br J Pharmacol; 2014 Jun; 171(12):3077-88. PubMed ID: 24611668
[TBL] [Abstract][Full Text] [Related]
52. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
Zhou SF
Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
[TBL] [Abstract][Full Text] [Related]
53. Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats.
Wang Y; Wang H; Zhang L; Zhang Y; Sheng Y; Deng G; Li S; Cao N; Guan H; Cheng X; Wang C
J Ethnopharmacol; 2019 Jun; 238():111866. PubMed ID: 30970283
[TBL] [Abstract][Full Text] [Related]
54. Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain.
Niwa T; Okada K; Hiroi T; Imaoka S; Narimatsu S; Funae Y
Biol Pharm Bull; 2008 Mar; 31(3):348-51. PubMed ID: 18310890
[TBL] [Abstract][Full Text] [Related]
55. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
56. Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Jeong H
Mol Pharmacol; 2015 Jul; 88(1):106-12. PubMed ID: 25943116
[TBL] [Abstract][Full Text] [Related]
57. Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine.
McMillan DM; Tyndale RF
Neuropsychopharmacology; 2015 Jun; 40(7):1804-12. PubMed ID: 25630571
[TBL] [Abstract][Full Text] [Related]
58. Comparison of catalytical activity and stereoselectivity between the recombinant human cytochrome P450 2D6.1 and 2D6.10.
Kong LM; Qian MR; Hu HH; Xu SY; Yu LS; Jiang HD; Chen SQ; Zeng S
Pharmazie; 2012 May; 67(5):440-7. PubMed ID: 22764579
[TBL] [Abstract][Full Text] [Related]
59. Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and response.
Sowinski KM; Burlew BS
Pharmacotherapy; 1997; 17(6):1305-10. PubMed ID: 9399616
[TBL] [Abstract][Full Text] [Related]
60. Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites.
Tweedie DJ; Burke MD
Drug Metab Dispos; 1987; 15(1):74-81. PubMed ID: 2881762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
